{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:05:09Z","timestamp":1753891509206,"version":"3.41.2"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.01226","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T14:40:03Z","timestamp":1575038403000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["N-Terminal Pro B-Type Natriuretic Peptide's Usefulness for Paroxysmal Atrial Fibrillation Detection Among Populations Carrying Cardiovascular Risk Factors"],"prefix":"10.3389","volume":"10","author":[{"given":"Elena","family":"Pal\u00e0","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Bustamante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep Lluis","family":"Cl\u00faa-Espuny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Gonzalez-Loyola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Ballesta-Ors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Pagola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alonso","family":"Pedrote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel Angel","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Montaner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,29]]},"reference":[{"volume-title":"The Burden of Stroke in Europe Report.","year":"2017","author":"Stevens","key":"B1"},{"key":"B2","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1212\/WNL.28.10.973","article-title":"Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study","volume":"28","author":"Wolf","year":"1978","journal-title":"Neurology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.rec.2013.03.003","article-title":"Prevalence of undiagnosed atrial fibrillation and of that not being treated with anticoagulant drugs : the AFABE study","volume":"66","author":"Roso-llorach","year":"2013","journal-title":"Rev Esp Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"134756","DOI":"10.1155\/2015\/134756","article-title":"Results from the registry of atrial fibrillation (AFABE): gap between undiagnosed and registered atrial fibrillation in adults \u2014 ineffectiveness of oral anticoagulation treatment with VKA","volume":"2015","author":"Panisello-tafalla","year":"2015","journal-title":"Biomed Res Int"},{"key":"B6","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S1885-5857(10)70188-2","article-title":"Prevalence of atrial fibrillation and use of antithrombotics in hypertensive patients aged \u2265 65 years","volume":"63","author":"Morillas","year":"2010","journal-title":"Rev Esp Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.rec.2016.11.033","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"70","author":"Kirchhof","year":"2017","journal-title":"Rev Esp Cardiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1161\/CIRCULATIONAHA.116.026693","article-title":"Screening for atrial fibrillation: a report of the AF-SCREEN international collaboration","volume":"135","author":"Freedman","year":"2017","journal-title":"Circulation."},{"key":"B9","doi-asserted-by":"publisher","first-page":"CD009586","DOI":"10.1002\/14651858.CD009586.pub3","article-title":"Systematic screening for the detection of atrial fibrillation","volume":"2016","author":"Moran","year":"2016","journal-title":"Cochrane Database Syst Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1161\/CIRCULATIONAHA.114.014343","article-title":"Mass screening for untreated atrial fibrillation the STROKESTOP study","volume":"131","author":"Svennberg","year":"2015","journal-title":"Circulation."},{"key":"B11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1160\/TH13-02-0165","article-title":"Screening to identify unknown atrial fibrillation: a systematic review","volume":"110","author":"Lowres","year":"2013","journal-title":"Thromb Haemost."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1161\/STROKEAHA.114.008311","article-title":"B-type natriuretic peptides help in cardioembolic stroke diagnosis","volume":"46","author":"Llombart","year":"2015","journal-title":"Stroke."},{"key":"B13","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/europace\/euw101","article-title":"CHA2DS2-VASc score and blood biomarkers to identify patients with atrial high-rate episodes and paroxysmal atrial fibrillation","volume":"19","author":"Wakula","year":"2017","journal-title":"Europace."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e000182","DOI":"10.1136\/openhrt-2014-000182","article-title":"Natriuretic peptides for the detection of paroxysmal atrial fibrillation","volume":"2","author":"Seegers","year":"2015","journal-title":"Open Hear."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1136\/heartjnl-2016-310236","article-title":"N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation","volume":"103","author":"Svennberg","year":"2017","journal-title":"Heart."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e0212974","DOI":"10.1371\/journal.pone.0212974","article-title":"Assessment of N-terminal pro-brain natriuretic peptide level in the screening for atrial fibrillation in the primary health care","volume":"14","author":"Ghazal","year":"2019","journal-title":"PLoS ONE."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.4022\/jafib.1124","article-title":"Von Willebrand factor plasma levels variability in nonvalvular atrial fibrillation","volume":"7","author":"Mu\u00f1oz-Cort\u00e9s","year":"2014","journal-title":"J Atr Fibrillation."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1161\/STROKEAHA.117.017076","article-title":"Blood biomarkers for the early diagnosis of stroke: the stroke-chip study","volume":"48","author":"Bustamante","year":"2017","journal-title":"Stroke."},{"key":"B19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1160\/TH10-09-0615","article-title":"Levels of von Willebrand factor and ADAMTS13 determine clinical outcome after cardioversion for atrial fibrillation","volume":"105","author":"Freynhofer","year":"2011","journal-title":"Thromb Haemost."},{"key":"B20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.joa.2017.05.003","article-title":"Association between serum soluble urokinase-type plasminogen activator receptor and atrial fibrillation","volume":"33","author":"Ichihara","year":"2017","journal-title":"J Arrhythmia."},{"key":"B21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ijcard.2017.10.063","article-title":"Yield of atrial fibrillation detection with Textile Wearable Holter from the acute phase of stroke: pilot study of Crypto-AF registry","volume":"251","author":"Pagola","year":"2018","journal-title":"Int J Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation."},{"key":"B23","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.116.023163","article-title":"Modifiable risk factors and atrial fibrillation","volume":"136","author":"Lau","year":"2017","journal-title":"Circulation."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","article-title":"Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT","volume":"38","author":"Van Gelder","year":"2017","journal-title":"Eur Heart J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1001\/jamacardio.2017.3180","article-title":"Incidence of previously undiagnosed atrial fibrillation using insertable cardiac monitors in a high-risk population: the REVEAL AF study","volume":"2","author":"Reiffel","year":"2017","journal-title":"JAMA Cardiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1161\/STROKEAHA.119.025169","article-title":"Prolonged cardiac rhythm monitoring and secondary stroke prevention in patients with cryptogenic cerebral ischemia","volume":"50","author":"Tsivgoulis","year":"2019","journal-title":"Stroke."},{"key":"B27","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/eurheartj\/ehn599","article-title":"Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation","volume":"31","author":"Friberg","year":"2010","journal-title":"Eur Heart J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/clc.22701","article-title":"Thromboembolic risk and effect of oral anticoagulation according to atrial fibrillation patterns: a systematic review and meta-analysis","volume":"40","author":"Lilli","year":"2017","journal-title":"Clin Cardiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jacep.2015.04.010","article-title":"A systematic review on the progression of paroxysmal to persistent atrial fibrillation: Shedding new light on the effects of catheter ablation","volume":"1","author":"Proietti","year":"2015","journal-title":"JACC Clin Electrophysiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/pace.12264","article-title":"Evaluation of time course and predicting factors of progression of paroxysmal or persistent atrial fibrillation to permanent atrial fibrillation","volume":"37","author":"De Sisti","year":"2014","journal-title":"Pacing Clin Electrophysiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s13311-011-0048-y","article-title":"Prevention of cardioembolic stroke","volume":"8","author":"Freeman","year":"2011","journal-title":"Neurotherapeutics."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3109\/07853890.2010.526630","article-title":"B-type natriuretic peptides: Looking to the future","volume":"43","author":"Troughton","year":"2011","journal-title":"Ann Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e623","DOI":"10.1161\/CIR.0000000000000568","article-title":"Atrial fibrillation burden: moving beyond atrial fibrillation as a binary entity: a scientific statement from the american heart association","volume":"137","author":"Chen","year":"2018","journal-title":"Circulation."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1016\/S0140-6736(16)00741-8","article-title":"The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study","volume":"387","author":"Hijazi","year":"2016","journal-title":"Lancet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source","volume":"378","author":"Hart","year":"2018","journal-title":"N Engl J Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1161\/STROKEAHA.116.016414","article-title":"Embolic stroke of undetermined source: a systematic review and clinical update","volume":"48","author":"Hart","year":"2017","journal-title":"Stroke."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1756286419851381","article-title":"Embolic strokes of undetermined source: theoretical construct or useful clinical tool?","volume":"12","author":"Tsivgoulis","year":"2019","journal-title":"Ther Adv Neurol Disord."},{"key":"B39","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/1747493018799981","article-title":"The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: rationale and methods","volume":"14","author":"Kamel","year":"2019","journal-title":"Int J Stroke."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.01226\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T14:40:06Z","timestamp":1575038406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.01226\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,29]]},"references-count":39,"alternative-id":["10.3389\/fneur.2019.01226"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.01226","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2019,11,29]]},"article-number":"1226"}}